☰

Chengyin Min, Ph.D. - Publications

Affiliations: 
2009 Boston University, Boston, MA, United States 
Area:
Molecular Biology
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Min C, Zhao Y, Romagnoli M, Trackman PC, Sonenshein GE, Kirsch KH. Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis. Journal of Cellular Biochemistry. 111: 1160-8. PMID 20717927 DOI: 10.1002/Jcb.22828  0.729
2009 Min C, Yu Z, Kirsch KH, Zhao Y, Vora SR, Trackman PC, Spicer DB, Rosenberg L, Palmer JR, Sonenshein GE. A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer Research. 69: 6685-93. PMID 19654310 DOI: 10.1158/0008-5472.Can-08-4818  0.743
2009 Wang X, Belguise K, O'Neill CF, Sánchez-Morgan N, Romagnoli M, Eddy SF, Mineva ND, Yu Z, Min C, Trinkaus-Randall V, Chalbos D, Sonenshein GE. RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1. Molecular and Cellular Biology. 29: 3832-44. PMID 19433448 DOI: 10.1128/Mcb.00032-09  0.572
2009 Zhao Y, Min C, Vora SR, Trackman PC, Sonenshein GE, Kirsch KH. The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells. The Journal of Biological Chemistry. 284: 1385-93. PMID 19029090 DOI: 10.1158/0008-5472.Sabcs-4073  0.722
2008 Min C, Eddy SF, Sherr DH, Sonenshein GE. NF-kappaB and epithelial to mesenchymal transition of cancer. Journal of Cellular Biochemistry. 104: 733-44. PMID 18253935 DOI: 10.1002/Jcb.21695  0.655
2007 Wu M, Min C, Wang X, Yu Z, Kirsch KH, Trackman PC, Sonenshein GE. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Research. 67: 6278-85. PMID 17616686 DOI: 10.1158/0008-5472.Can-07-0776  0.719
2007 Min C, Kirsch KH, Zhao Y, Jeay S, Palamakumbura AH, Trackman PC, Sonenshein GE. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Research. 67: 1105-12. PMID 17283144 DOI: 10.1158/0008-5472.Can-06-3867  0.752
Show low-probability matches.